American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

FOLD

FOLD Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

FOLD historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of FOLD by members of U.S. Congress

Politician Type Traded
Daniel S. Goldman House / D Sale $1,001 - $15,000 Apr 10, 2023
FOLD Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
FOLD Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
FOLD Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in FOLD holdings by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard
Insider Trading

Quarterly net insider trading by FOLD's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $20,000 Jul 16, 2026 Issue: Health Issues Medicare/Medicaid
  • $30,000 Apr 18, 2026 Issue: Health Issues Medicare/Medicaid
  • $10,000 Jan 02, 2026 Issue: Health Issues
  • $10,000 Oct 02, 2025 Issue: Health Issues
  • $10,000 Jul 01, 2025 Issue: Health Issues
  • $10,000 Apr 02, 2025 Issue: Health Issues
  • $10,000 Jan 05, 2025 Issue: Health Issues
  • $10,000 Oct 10, 2024 Issue: Health Issues
  • $10,000 Jul 02, 2024 Issue: Health Issues
  • $10,000 Oct 05, 2023 Issue: Health Issues
  • $20,000 Jul 21, 2023 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
  • $10,000 Jun 30, 2023 Issue: Health Issues
  • $20,000 Jan 23, 2023 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
  • $10,000 Jan 01, 2023 Issue: Health Issues
  • $20,000 Oct 24, 2022 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
  • $10,000 Oct 04, 2022 Issue: Health Issues
  • $20,000 Jul 27, 2022 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
  • $10,000 Jul 05, 2022 Issue: Health Issues
  • $20,000 Apr 20, 2022 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
  • $10,000 Apr 04, 2022 Issue: Health Issues
  • $20,000 Jan 30, 2022 Issue: Medicare/Medicaid Health Issues Medical/Disease Research/Clinical Labs
  • $10,000 Jan 04, 2022 Issue: Health Issues
  • $20,000 Oct 27, 2021 Issue: Health Issues Medical/Disease Research/Clinical Labs Medicare/Medicaid
  • $10,000 Oct 01, 2021 Issue: Health Issues
  • $20,000 Jul 20, 2021 Issue: Health Issues Medicare/Medicaid Medical/Disease Research/Clinical Labs
  • $10,000 Jul 06, 2021 Issue: Health Issues
  • $20,000 Apr 22, 2021 Issue: Medical/Disease Research/Clinical Labs Medicare/Medicaid Health Issues
  • $10,000 Apr 15, 2021 Issue: Health Issues
  • $10,000 Jan 05, 2021 Issue: Health Issues
  • $10,000 Oct 02, 2020 Issue: Health Issues
  • $10,000 Jul 16, 2020 Issue: Health Issues
  • $10,000 Apr 11, 2020 Issue: Health Issues
  • $10,000 Jan 13, 2020 Issue: Health Issues
  • $20,000 Jan 10, 2020 Issue: Medical/Disease Research/Clinical Labs Health Issues Medicare/Medicaid
  • $20,000 Oct 18, 2019 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs Health Issues
  • $10,000 Oct 15, 2019 Issue: Health Issues
  • $10,000 Jul 05, 2019 Issue: Health Issues
  • $10,000 Apr 17, 2019 Issue: Health Issues
  • $10,000 Jan 16, 2019 Issue: Health Issues
  • $10,000 Oct 15, 2018 Issue: Health Issues
  • $10,000 Jul 18, 2018 Issue: Health Issues
  • $10,000 Apr 10, 2018 Issue: Health Issues
  • $10,000 Jan 19, 2018 Issue: Health Issues
  • $10,000 Oct 20, 2017 Issue: Health Issues
  • $10,000 Jul 20, 2017 Issue: Health Issues
  • $10,000 Apr 21, 2017 Issue: Health Issues
  • $10,000 Jan 20, 2017 Issue: Health Issues
  • $10,000 Oct 20, 2016 Issue: Health Issues
  • $10,000 Jul 20, 2016 Issue: Health Issues
  • $10,000 Apr 19, 2016 Issue: Health Issues
  • $10,000 Jan 20, 2016 Issue: Health Issues
  • $15,000 Oct 20, 2015 Issue: Health Issues
  • $15,000 Jul 20, 2015 Issue: Health Issues
  • $10,000 Oct 15, 2010 Issue: Health Issues
  • $20,000 Jul 16, 2010 Issue: Health Issues
Revolving Door

Former government officials who have lobbied for FOLD

Quiver Logo

No former government officials on record as having lobbied for FOLD

Revolving Door Dashboard
Corporate Lobbying

FOLD Estimated quarterly lobbying spending

Revenue Breakdown

FOLD Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
FOLD Income Statement
FOLD Balance Sheet
FOLD Cash Flow
U.S. Patents

New FOLD patent grants

  • Patent Title: Drug package Aug. 12, 2025
  • Patent Title: Drug package Jul. 08, 2025
  • Patent Title: Method to predict response to pharmacological chaperone treatment of diseases Jun. 29, 2021
  • Patent Title: Drug package Mar. 10, 2020
  • Patent Title: Drug package Nov. 19, 2019
  • Patent Title: Drug package Mar. 26, 2019
  • Patent Title: Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones Jun. 19, 2018
  • Patent Title: Compounds and methods for the treatment of alzheimer's disease and/or cerebral amyloid angiopathy Jun. 12, 2018
  • Patent Title: Methods for treatment of fabry disease Jun. 05, 2018
  • Patent Title: Pharmacological chaperones for treating obesity Apr. 10, 2018
  • Patent Title: Method for treating cerebral amyloid angiopathy using pharmacological chaperones to increase the activity of gangliosidases Apr. 03, 2018
  • Patent Title: Chemical crosslinkers Feb. 13, 2018
  • Patent Title: Compounds and method for treating or preventing disease conditions associated with alpha-1-antitrypsin Jan. 16, 2018
  • Patent Title: Stable parenteral dnj compositions Nov. 28, 2017
  • Patent Title: Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity Nov. 21, 2017
  • Patent Title: Compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system Sep. 05, 2017
  • Patent Title: Α-galactosidase a and 1-deoxygalactonojirimycin co-formulation Jul. 04, 2017
  • Patent Title: Dosing regimens for treating and/or preventing cerebral amyloidoses Jun. 13, 2017
  • Patent Title: Sugar derivatives comprising sulfur-containing moieties and methods of making same and methods of using the same for the treatment of mps iiic Mar. 21, 2017
  • Patent Title: Treatment of cns disorders associated with mutations in genes encoding lysosomal enzymes Mar. 21, 2017
  • Patent Title: Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity Feb. 14, 2017
  • Patent Title: Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases Jan. 17, 2017
  • Patent Title: Method to predict response to pharmacological chaperone treatment of diseases Jan. 17, 2017
  • Patent Title: Method for preparing isofagomine and its derivatives Nov. 01, 2016
  • Patent Title: Methods for treatment of fabry disease Nov. 01, 2016
  • Patent Title: Compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system Oct. 11, 2016
  • Patent Title: Compositions for preventing and/or treating degenerative disorders of the central nervous system Aug. 09, 2016
  • Patent Title: High concentration alpha-glucosidase compositions for the treatment of pompe disease Aug. 02, 2016
  • Patent Title: Method for the treatment of neurological disorders by enhancing the activity of β-glucocerebrosidase Aug. 02, 2016
  • Patent Title: Pharmacological chaperones for treating obesity Jul. 05, 2016
  • Patent Title: High concentration α-glucosidase compositions for the treatment of pompe disease Apr. 05, 2016
  • Patent Title: Signal sequences to improve protein expressions and secretion of recombinant enzymes and other proteins Mar. 08, 2016
  • Patent Title: Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity Feb. 09, 2016
  • Patent Title: Utilization of pharmacological chaperones to improve manufacturing and purification of biologics Dec. 08, 2015
  • Patent Title: Method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives Nov. 10, 2015
  • Patent Title: Method for the treatment of neurological disorders by enhancing the activity of beta-glucocerebrosidase Sep. 01, 2015
  • Patent Title: Method to predict response to pharmacological chaperone treatment of diseases Aug. 04, 2015
  • Patent Title: Dosing regimens for the treatment of lysosomal storage diseases using pharmacological chaperones Jun. 16, 2015
  • Patent Title: Method for treating alzheimer's disease using pharmacological chaperones to increase the activity of gangliosidases Jun. 02, 2015
  • Patent Title: Methods for treatment of fabry disease Apr. 07, 2015
  • Patent Title: Compounds and methods for treating or preventing disease conditions associated with α-1-antitrypsin Mar. 31, 2015
  • Patent Title: Variant, recombinant beta-glucocerebrosidase proteins with increased stability and increased retained catalytic activity Feb. 24, 2015
  • Patent Title: Methods for preventing and/or treating lysosomal storage disorders Jan. 27, 2015
  • Patent Title: Compositions for preventing and/or treating degenerative disorders of the central nervous system Dec. 10, 2013
  • Patent Title: Compositions for preventing and/or treating lysosomal storage disorders Dec. 10, 2013
  • Patent Title: Method to predict response to pharmacological chaperone treatment of diseases Nov. 26, 2013
  • Patent Title: Method for preparing isofagomine and its derivatives Jul. 16, 2013
  • Patent Title: Mouse model for pompe disease and methods of use thereof Jun. 18, 2013
  • Patent Title: Treatment of gaucher disease with specific pharmacological chaperones and monitoring treatment using surrogate markers Mar. 19, 2013
  • Patent Title: Multiple compartment dosing model Nov. 27, 2012
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to FOLD from public contracts

FOLD News

Recent insights relating to FOLD

CNBC Recommendations

Recent picks made for FOLD stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in FOLD

FOLD Analyst Ratings

FOLD Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
FOLD Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $FOLD stock a Buy, Sell, or Hold?

  • What is the price target for $FOLD stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

FOLD Top Shareholders
Shareholder
Shares Held
FOLD Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $FOLD stock?

  • Who owns the most shares of $FOLD stock?

  • What funds own $FOLD stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

FOLD Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view FOLD Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About FOLD

No description available

FOLD (FOLD) Historical Stock Prices

FOLD (FOLD) closed at $14.49 on April 24, 2026. Over the past year its adjusted close ranged from $5.64 to $14.49. Daily prices go back to January 2, 2014, 3,096 trading days in all.

  • 1 month+0.42%
  • 3 months+1.54%
  • Year to date+1.76%
  • 1 year+101.25%
  • 3 years+25.45%
  • 5 years+44.76%
  • Max+501.24%
See every congressional and insider trade on the FOLD price chart

Quiver Premium charts FOLD's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Apr 24, 2026 14.49 14.50 14.49 14.49 14.49 5,285,334
Apr 23, 2026 14.47 14.48 14.46 14.46 14.46 2,050,720
Apr 22, 2026 14.46 14.47 14.46 14.46 14.46 2,703,461
Apr 21, 2026 14.45 14.47 14.45 14.46 14.46 2,587,567
Apr 20, 2026 14.45 14.46 14.45 14.46 14.46 1,654,944
Apr 17, 2026 14.46 14.46 14.45 14.46 14.46 2,211,440
Apr 16, 2026 14.45 14.46 14.45 14.45 14.45 3,004,699
Apr 15, 2026 14.45 14.46 14.45 14.46 14.46 4,927,189
Apr 14, 2026 14.47 14.47 14.45 14.46 14.46 4,451,877
Apr 13, 2026 14.47 14.47 14.45 14.46 14.46 1,938,617
Apr 10, 2026 14.46 14.47 14.45 14.46 14.46 2,036,079
Apr 9, 2026 14.46 14.47 14.46 14.47 14.47 2,735,677
Apr 8, 2026 14.46 14.48 14.46 14.46 14.46 2,982,763
Apr 7, 2026 14.45 14.47 14.45 14.47 14.47 1,855,686
Apr 6, 2026 14.44 14.45 14.43 14.45 14.45 2,310,702
Apr 2, 2026 14.43 14.44 14.43 14.44 14.44 2,991,131
Apr 1, 2026 14.46 14.46 14.43 14.44 14.44 4,094,378
Mar 31, 2026 14.43 14.46 14.42 14.46 14.46 2,620,029
Mar 30, 2026 14.42 14.43 14.42 14.43 14.43 1,482,291
Mar 27, 2026 14.43 14.43 14.41 14.41 14.41 2,288,924
Mar 26, 2026 14.43 14.43 14.42 14.43 14.43 1,564,134
Mar 25, 2026 14.41 14.43 14.40 14.43 14.43 2,112,145
Mar 24, 2026 14.40 14.41 14.40 14.41 14.41 3,405,851
Mar 23, 2026 14.41 14.42 14.39 14.42 14.42 2,652,291
Mar 20, 2026 14.37 14.43 14.37 14.43 14.43 10,970,099
Mar 19, 2026 14.37 14.38 14.37 14.38 14.38 3,491,230
Mar 18, 2026 14.38 14.39 14.37 14.37 14.37 3,526,219
Mar 17, 2026 14.38 14.39 14.37 14.37 14.37 4,893,075
Mar 16, 2026 14.37 14.38 14.37 14.37 14.37 6,531,714
Mar 13, 2026 14.38 14.39 14.37 14.37 14.37 2,738,134
Mar 12, 2026 14.37 14.38 14.37 14.37 14.37 2,400,124
Mar 11, 2026 14.37 14.39 14.37 14.37 14.37 5,274,516
Mar 10, 2026 14.34 14.36 14.34 14.36 14.36 3,349,631
Mar 9, 2026 14.34 14.37 14.33 14.37 14.37 2,577,907
Mar 6, 2026 14.32 14.34 14.32 14.34 14.34 2,992,449
Mar 5, 2026 14.33 14.34 14.32 14.33 14.33 4,468,731
Mar 4, 2026 14.35 14.36 14.33 14.33 14.33 5,574,568
Mar 3, 2026 14.34 14.35 14.34 14.34 14.34 4,590,797
Mar 2, 2026 14.34 14.37 14.34 14.36 14.36 3,638,453
Feb 27, 2026 14.33 14.37 14.32 14.37 14.37 3,036,017
Feb 26, 2026 14.34 14.35 14.32 14.33 14.33 5,543,360
Feb 25, 2026 14.34 14.36 14.34 14.34 14.34 2,621,435
Feb 24, 2026 14.35 14.36 14.34 14.36 14.36 2,409,512
Feb 23, 2026 14.33 14.37 14.32 14.36 14.36 2,171,665
Feb 20, 2026 14.35 14.36 14.31 14.34 14.34 4,645,854
Feb 19, 2026 14.34 14.35 14.34 14.35 14.35 3,408,769
Feb 18, 2026 14.32 14.35 14.31 14.34 14.34 3,118,335
Feb 17, 2026 14.31 14.35 14.30 14.30 14.30 3,196,308
Feb 13, 2026 14.35 14.35 14.30 14.31 14.31 7,000,619
Feb 12, 2026 14.33 14.35 14.30 14.33 14.33 6,410,613
Feb 11, 2026 14.32 14.36 14.30 14.31 14.31 5,157,081
Feb 10, 2026 14.31 14.32 14.29 14.30 14.30 4,438,186
Feb 9, 2026 14.30 14.30 14.28 14.30 14.30 4,301,310
Feb 6, 2026 14.30 14.30 14.26 14.30 14.30 24,424,770
Feb 5, 2026 14.27 14.29 14.26 14.28 14.28 4,435,968
Feb 4, 2026 14.28 14.30 14.26 14.27 14.27 9,110,631
Feb 3, 2026 14.29 14.30 14.27 14.28 14.28 7,053,720
Feb 2, 2026 14.29 14.30 14.28 14.29 14.29 7,777,586
Jan 30, 2026 14.27 14.29 14.27 14.29 14.29 4,742,885
Jan 29, 2026 14.28 14.29 14.27 14.27 14.27 5,226,478
Jan 28, 2026 14.28 14.29 14.27 14.28 14.28 5,901,626
Jan 27, 2026 14.29 14.29 14.28 14.29 14.29 7,304,607
Jan 26, 2026 14.28 14.30 14.27 14.29 14.29 8,374,252
Jan 23, 2026 14.27 14.29 14.27 14.27 14.27 8,627,704
Jan 22, 2026 14.32 14.32 14.27 14.27 14.27 10,838,995
Jan 21, 2026 14.31 14.36 14.30 14.35 14.35 4,321,688
Jan 20, 2026 14.31 14.32 14.30 14.31 14.31 4,098,085
Jan 16, 2026 14.33 14.34 14.32 14.33 14.33 3,535,915
Jan 15, 2026 14.35 14.37 14.30 14.31 14.31 5,199,911
Jan 14, 2026 14.32 14.38 14.31 14.38 14.38 9,893,903
Jan 13, 2026 14.28 14.35 14.27 14.32 14.32 9,172,324
Jan 12, 2026 14.30 14.30 14.27 14.28 14.28 11,700,468
Jan 9, 2026 14.28 14.30 14.28 14.28 14.28 10,549,877
Jan 8, 2026 14.32 14.32 14.26 14.28 14.28 17,710,512
Jan 7, 2026 14.29 14.35 14.27 14.30 14.30 9,377,315
Jan 6, 2026 14.25 14.29 14.24 14.28 14.28 13,311,987
Jan 5, 2026 14.25 14.26 14.21 14.25 14.25 38,443,411
Jan 2, 2026 14.24 14.27 14.23 14.27 14.27 8,088,288
Dec 31, 2025 14.25 14.27 14.23 14.24 14.24 6,697,256
Dec 30, 2025 14.26 14.26 14.23 14.25 14.25 11,520,671
Dec 29, 2025 14.24 14.28 14.23 14.25 14.25 8,162,567
Dec 26, 2025 14.23 14.28 14.23 14.25 14.25 5,181,173
Dec 24, 2025 14.21 14.26 14.21 14.25 14.25 5,937,321
Dec 23, 2025 14.22 14.22 14.18 14.21 14.21 17,896,009
Dec 22, 2025 14.19 14.26 14.18 14.21 14.21 32,526,561
Dec 19, 2025 14.18 14.36 14.16 14.18 14.18 188,236,354
Dec 18, 2025 10.96 10.99 10.64 10.89 10.89 4,155,410
Dec 17, 2025 10.94 11.14 10.91 11.00 11.00 6,285,446
Dec 16, 2025 10.80 11.09 10.75 10.89 10.89 8,225,167
Dec 15, 2025 10.54 11.14 10.50 10.88 10.88 14,256,718
Dec 12, 2025 9.92 11.00 9.78 10.55 10.55 12,051,405
Dec 11, 2025 9.84 9.96 9.74 9.90 9.90 3,851,100
Dec 10, 2025 9.78 9.91 9.72 9.85 9.85 4,208,881
Dec 9, 2025 9.85 9.94 9.79 9.81 9.81 3,617,918
Dec 8, 2025 10.03 10.03 9.73 9.85 9.85 3,294,185
Dec 5, 2025 9.96 10.05 9.79 9.90 9.90 3,676,341
Dec 4, 2025 9.67 9.99 9.63 9.95 9.95 2,946,244
Dec 3, 2025 9.78 9.85 9.66 9.78 9.78 2,921,933
Dec 2, 2025 9.87 10.02 9.56 9.73 9.73 4,528,768
Dec 1, 2025 9.92 10.05 9.77 9.80 9.80 6,290,262
Nov 28, 2025 9.99 10.04 9.88 9.93 9.93 1,610,673
Nov 26, 2025 10.10 10.10 9.79 10.02 10.02 3,136,529
Nov 25, 2025 10.08 10.14 9.76 9.87 9.87 4,056,855
Nov 24, 2025 10.01 10.57 9.52 9.89 9.89 16,369,072
Nov 21, 2025 9.42 9.62 9.31 9.56 9.56 4,016,065
Nov 20, 2025 9.83 9.88 9.37 9.45 9.45 3,977,072
Nov 19, 2025 9.53 9.78 9.41 9.73 9.73 4,072,707
Nov 18, 2025 9.30 9.63 9.27 9.59 9.59 3,384,580
Nov 17, 2025 9.48 9.64 9.42 9.42 9.42 6,534,743
Nov 14, 2025 9.25 9.56 9.25 9.48 9.48 2,746,648
Nov 13, 2025 9.41 9.50 9.24 9.38 9.38 3,905,835
Nov 12, 2025 9.33 9.50 9.23 9.42 9.42 4,827,367
Nov 11, 2025 9.00 9.39 8.92 9.32 9.32 4,601,856
Nov 10, 2025 8.93 9.01 8.83 9.00 9.00 3,661,263
Nov 7, 2025 8.88 8.98 8.69 8.87 8.87 3,896,176
Nov 6, 2025 9.20 9.27 8.87 8.90 8.90 6,906,213
Nov 5, 2025 9.05 9.35 8.99 9.19 9.19 7,125,542
Nov 4, 2025 9.08 9.64 8.85 8.99 8.99 9,726,906
Nov 3, 2025 9.01 9.08 8.62 8.86 8.86 7,627,287
Oct 31, 2025 8.90 9.17 8.75 9.03 9.03 4,890,537
Oct 30, 2025 8.90 9.16 8.81 8.90 8.90 4,905,471
Oct 29, 2025 8.83 9.29 8.72 8.90 8.90 5,584,328
Oct 28, 2025 8.89 9.08 8.78 8.86 8.86 3,703,002
Oct 27, 2025 8.66 8.95 8.63 8.88 8.88 6,102,978
Oct 24, 2025 8.52 8.74 8.48 8.67 8.67 2,997,632
Oct 23, 2025 8.57 8.57 8.32 8.50 8.50 2,244,354
Oct 22, 2025 8.48 8.62 8.37 8.55 8.55 3,326,429
Oct 21, 2025 8.40 8.60 8.39 8.47 8.47 3,248,747
Oct 20, 2025 8.12 8.55 8.09 8.44 8.44 7,369,951
Oct 17, 2025 8.04 8.15 7.87 8.04 8.04 3,124,047
Oct 16, 2025 8.39 8.48 8.07 8.11 8.11 5,487,875
Oct 15, 2025 8.05 8.48 8.01 8.37 8.37 5,928,727
Oct 14, 2025 8.07 8.15 7.96 8.04 8.04 4,301,929
Oct 13, 2025 8.29 8.37 8.00 8.18 8.18 3,281,269
Oct 10, 2025 8.30 8.35 8.16 8.30 8.30 3,643,704
Oct 9, 2025 8.24 8.51 8.19 8.27 8.27 5,948,121
Oct 8, 2025 8.16 8.31 8.01 8.26 8.26 3,764,870
Oct 7, 2025 8.31 8.31 8.03 8.16 8.16 3,321,290
Oct 6, 2025 8.22 8.43 8.13 8.16 8.16 4,235,174
Oct 3, 2025 8.25 8.59 8.11 8.20 8.20 6,600,235
Oct 2, 2025 7.74 8.30 7.74 8.25 8.25 9,970,735
Oct 1, 2025 7.97 8.44 7.68 7.71 7.71 14,116,338
Sep 30, 2025 7.95 8.00 7.83 7.88 7.88 4,556,096
Sep 29, 2025 8.28 8.34 7.72 7.94 7.94 8,565,996
Sep 26, 2025 8.35 8.35 8.07 8.24 8.24 4,770,151
Sep 25, 2025 8.40 8.46 8.23 8.32 8.32 3,285,602
Sep 24, 2025 8.12 8.42 8.12 8.35 8.35 2,842,144
Sep 23, 2025 8.52 8.68 8.14 8.16 8.16 3,884,443
Sep 22, 2025 8.29 8.58 8.22 8.57 8.57 4,285,100
Sep 19, 2025 8.41 8.44 8.13 8.33 8.33 13,465,911
Sep 18, 2025 8.48 8.52 8.26 8.48 8.48 9,460,775
Sep 17, 2025 7.99 8.12 7.88 7.97 7.97 4,990,964
Sep 16, 2025 7.73 8.29 7.61 8.01 8.01 7,491,392
Sep 15, 2025 8.01 8.08 7.68 7.73 7.73 3,394,050
Sep 12, 2025 8.00 8.11 7.92 7.99 7.99 2,877,575
Sep 11, 2025 7.96 8.05 7.89 8.02 8.02 1,907,061
Sep 10, 2025 7.83 8.11 7.79 7.94 7.94 3,540,957
Sep 9, 2025 7.99 7.99 7.80 7.89 7.89 2,644,702
Sep 8, 2025 8.03 8.19 7.95 7.98 7.98 3,388,206
Sep 5, 2025 8.08 8.19 7.99 7.99 7.99 5,559,297
Sep 4, 2025 7.83 8.03 7.81 8.02 8.02 5,572,392
Sep 3, 2025 7.90 7.99 7.69 7.85 7.85 5,272,635
Sep 2, 2025 7.71 7.90 7.61 7.88 7.88 4,561,381
Aug 29, 2025 7.67 7.75 7.56 7.59 7.59 4,153,629
Aug 28, 2025 7.63 7.79 7.59 7.65 7.65 3,623,470
Aug 27, 2025 7.41 7.68 7.41 7.64 7.64 2,000,046
Aug 26, 2025 7.44 7.56 7.40 7.52 7.52 2,920,136
Aug 25, 2025 7.55 7.63 7.42 7.48 7.48 3,126,438
Aug 22, 2025 7.70 7.77 7.58 7.61 7.61 3,924,063
Aug 21, 2025 7.31 7.64 7.31 7.60 7.60 3,423,589
Aug 20, 2025 7.35 7.44 7.29 7.40 7.40 2,458,953
Aug 19, 2025 7.41 7.46 7.28 7.34 7.34 2,641,992
Aug 18, 2025 7.37 7.51 7.36 7.41 7.41 3,770,856
Aug 15, 2025 7.20 7.42 7.15 7.40 7.40 4,667,840
Aug 14, 2025 7.16 7.35 7.10 7.12 7.12 5,221,717
Aug 13, 2025 7.05 7.28 6.98 7.19 7.19 6,828,436
Aug 12, 2025 6.72 7.01 6.71 6.98 6.98 3,250,701
Aug 11, 2025 6.74 6.91 6.61 6.66 6.66 2,932,219
Aug 8, 2025 6.77 6.84 6.68 6.76 6.76 3,934,694
Aug 7, 2025 6.94 6.95 6.59 6.79 6.79 4,078,587
Aug 6, 2025 6.95 7.07 6.84 6.93 6.93 3,926,265
Aug 5, 2025 6.82 7.04 6.74 6.99 6.99 4,595,866
Aug 4, 2025 6.34 6.94 6.28 6.83 6.83 7,853,842
Aug 1, 2025 5.96 6.35 5.92 6.32 6.32 5,961,673
Jul 31, 2025 6.29 6.38 5.97 5.99 5.99 8,283,756
Jul 30, 2025 6.14 6.40 6.09 6.13 6.13 4,113,285
Jul 29, 2025 6.14 6.18 6.06 6.13 6.13 3,571,002
Jul 28, 2025 6.17 6.24 6.08 6.12 6.12 4,439,773
Jul 25, 2025 6.27 6.29 5.97 6.06 6.06 3,505,161
Jul 24, 2025 6.36 6.37 6.21 6.28 6.28 3,082,170
Jul 23, 2025 6.29 6.37 6.16 6.31 6.31 3,348,124
Jul 22, 2025 6.03 6.22 6.03 6.22 6.22 3,464,763
Jul 21, 2025 6.00 6.12 5.95 6.05 6.05 3,632,497
Jul 18, 2025 6.35 6.35 5.92 5.96 5.96 5,161,913
Jul 17, 2025 6.55 6.77 6.28 6.29 6.29 5,224,662
Jul 16, 2025 5.96 6.09 5.93 6.07 6.07 3,273,097
Jul 15, 2025 6.29 6.31 5.88 5.91 5.91 2,983,836
Jul 14, 2025 6.08 6.25 6.05 6.24 6.24 2,328,041
Jul 11, 2025 6.28 6.28 6.08 6.09 6.09 2,557,717
Jul 10, 2025 6.44 6.44 6.22 6.30 6.30 4,188,297
Jul 9, 2025 6.28 6.45 6.27 6.42 6.42 5,592,665
Jul 8, 2025 6.05 6.25 6.04 6.22 6.22 4,186,237
Jul 7, 2025 6.10 6.16 6.01 6.05 6.05 5,480,573
Jul 3, 2025 6.01 6.15 5.97 6.10 6.10 3,120,129
Jul 2, 2025 5.82 5.97 5.78 5.95 5.95 3,866,190
Jul 1, 2025 5.70 5.99 5.66 5.84 5.84 5,184,467
Jun 30, 2025 5.90 5.92 5.72 5.73 5.73 5,467,328
Jun 27, 2025 5.69 5.95 5.64 5.93 5.93 9,952,134
Jun 26, 2025 5.72 5.78 5.55 5.69 5.69 4,149,393
Jun 25, 2025 5.70 5.73 5.51 5.66 5.66 2,700,031
Jun 24, 2025 5.76 5.82 5.63 5.71 5.71 3,997,313
Jun 23, 2025 5.63 5.79 5.58 5.71 5.71 5,706,517
Jun 20, 2025 5.75 5.77 5.62 5.64 5.64 17,425,362
Jun 18, 2025 5.78 5.88 5.71 5.73 5.73 5,415,440
Jun 17, 2025 5.99 5.99 5.78 5.80 5.80 6,174,552
Jun 16, 2025 6.07 6.15 5.89 6.05 6.05 6,885,169
Jun 13, 2025 6.05 6.22 6.01 6.03 6.03 4,224,896
Jun 12, 2025 6.13 6.19 6.00 6.17 6.17 3,856,610
Jun 11, 2025 6.17 6.23 6.09 6.14 6.14 4,799,315
Jun 10, 2025 6.09 6.22 6.05 6.11 6.11 3,446,759
Jun 9, 2025 6.19 6.20 6.02 6.03 6.03 4,597,825
Jun 6, 2025 6.03 6.19 6.00 6.16 6.16 5,145,581
Jun 5, 2025 6.10 6.12 5.90 5.96 5.96 3,732,477
Jun 4, 2025 6.24 6.32 6.09 6.10 6.10 4,522,470
Jun 3, 2025 6.15 6.36 6.11 6.26 6.26 5,044,090
Jun 2, 2025 6.09 6.20 6.06 6.16 6.16 3,874,184
May 30, 2025 6.18 6.20 6.03 6.07 6.07 3,291,139
May 29, 2025 6.13 6.37 6.05 6.21 6.21 7,003,579
May 28, 2025 6.27 6.33 6.10 6.10 6.10 5,503,660
May 27, 2025 6.32 6.38 6.18 6.24 6.24 4,436,665
May 23, 2025 6.15 6.27 6.12 6.22 6.22 2,822,292
May 22, 2025 6.30 6.35 6.20 6.26 6.26 2,995,155
May 21, 2025 6.52 6.58 6.24 6.34 6.34 3,627,226
May 20, 2025 6.50 6.65 6.39 6.59 6.59 4,099,140
May 19, 2025 6.38 6.51 6.26 6.42 6.42 5,792,808
May 16, 2025 5.96 6.44 5.91 6.43 6.43 8,141,540
May 15, 2025 5.90 5.96 5.81 5.95 5.95 4,214,094
May 14, 2025 6.03 6.11 5.87 5.88 5.88 3,354,981
May 13, 2025 6.20 6.23 6.01 6.02 6.02 3,770,726
May 12, 2025 6.17 6.31 6.09 6.21 6.21 6,698,108
May 9, 2025 6.09 6.29 5.97 5.98 5.98 8,856,154
May 8, 2025 5.98 6.25 5.82 6.08 6.08 9,231,289
May 7, 2025 6.24 6.26 5.92 6.09 6.09 5,657,301
May 6, 2025 6.50 6.58 6.13 6.19 6.19 5,544,969
May 5, 2025 6.64 6.73 6.50 6.53 6.53 4,239,565
May 2, 2025 6.69 6.80 6.53 6.67 6.67 6,371,917
May 1, 2025 6.62 7.07 6.56 6.68 6.68 10,697,496
Apr 30, 2025 7.49 7.71 7.37 7.68 7.68 4,493,694
Apr 29, 2025 7.36 7.58 7.33 7.52 7.52 3,739,290
Apr 28, 2025 7.35 7.41 7.26 7.39 7.39 4,267,093
Apr 25, 2025 7.14 7.38 7.05 7.35 7.35 3,683,901
Apr 24, 2025 7.14 7.21 7.01 7.20 7.20 4,644,682

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
FOLD Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at FOLD, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation